Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Cyclohexene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexene SCHEMBL2128923 | 1.00 | CA1 (0.39) | CA1CA2CA9ALDH1A1 | |
| Cyclohexene SCHEMBL11267115 | 0.96 | CA1 (0.36) | CA1CA2CA9 | |
| Cyclooctene SCHEMBL29059019 | 0.96 | CA1 (0.36) | CA1CA2CA9 | |
| Cyclohexene SCHEMBL11493765 | 0.96 | CA1 (0.36) | CA1CA2CA9 | |
| Bicarbonate SCHEMBL4050127 | 0.96 | CA1 (0.36) | CA1CA2CA9 | |
| Cyclohexene SCHEMBL28582823 | 0.93 | CA1 (0.33) | CA1CA2CA9 | |
| Cyclopentene SCHEMBL4818209 | 0.92 | — | — | |
| Cyclohexene SCHEMBL7058650 | 0.88 | — | — | |
| Cyclohexene SCHEMBL23409884 | 0.86 | FFAR3 (0.47) | — | |
| Cyclohexene SCHEMBL8603970 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 653 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025772-A | Method for preparing polyurethane-based solid electrolyte with high thermal stability based on coating method and application | 北京工业大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122025773-A | Coating preparation method of ultrathin high-toughness high-pressure-resistant block polyurethane solid electrolyte and application of lithium ion battery | 北京工业大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | SOLVAY SPECIALTY POLYMERS IT (IT) | 2026-04-16 | — | — | US | claimed |
| EP-4602667-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | Solvay Specialty Polymers Italy S.p.A. (IT) | 2025-08-20 | — | — | EP | claimed |
| US-20250243118-A1 | METHODS OF FORMING CERAMIC SUBSTRATES | CORNING INCORPORATED | 2025-07-31 | — | — | US | claimed |
| WO-2025131951-A1 | LITHIUM SECONDARY BATTERY WITH HIGH ENERGY DENSITY AND SAFETY | SOLVAY SPECIALTY POLYMERS ITALY S.P.A. (IT) | 2025-06-26 | — | — | WO | claimed |
| WO-2025136736-A1 | SLIP COMPOSITION FOR FORMING GREEN TAPE SUITABLE FOR CONTINUOUS SINTERING AND METHODS INVOLVING SAME | CORNING INCORPORATED (US) | 2025-06-26 | — | — | WO | claimed |
| CN-120019515-A | Lithium secondary battery with enhanced safety | 索尔维特殊聚合物意大利有限公司 | 2025-05-16 | — | — | CN | claimed |
| WO-2025093455-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED ENERGY DENSITY | SPECIALTY OPERATIONS FRANCE (FR) | 2025-05-08 | — | — | WO | claimed |
| CN-116479652-B | Polyester spinning oil containing cyclic carbonate and preparation method thereof | 浙江恒逸石化研究院有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-2013053665-A1 | POLYURETHANE, ITS PREPARATION PROCESS AND USES THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-04-18 | — | — | WO | claimed |
| CN-103003362-A | Biodegradable blends and films with nanostructured features | KIMBERLY CLARK CO | 2013-03-27 | — | — | CN | claimed |
| US-7375224-B2 | Adenine modified silica-based catalyst, a process for the preparation and use there for the production of cyclic carbonates | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-05-20 | — | — | US | claimed |
| US-20070276146-A1 | Adenine modified silica-based catalyst, a process for the preparation and use there for the production of cyclic carbonates | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-11-29 | — | — | US | claimed |
| EP-1589031-B1 | Production of polyketides and other natural products | BIOTICA TECH LTD (GB) | 2007-08-15 | — | — | EP | claimed |
| US-20060094893-A1 | Process for preparing cyclic carbonates | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-05-04 | — | — | US | claimed |
| EP-1592655-A2 | ESTERS OF CONJUGATED UNSATURATED ACIDS (CONJUGATED ACID ESTERS), CORRESPONDING METHODS AND USE | BASF Coatings Aktiengesellschaft (DE) | 2005-11-09 | — | — | EP | claimed |
| WO-2004069969-A2 | ESTERS OF CONJUGATED UNSATURATED ACIDS (CONJUGATED ACID ESTERS), CORRESPONDING METHODS AND USE | BASF COATINGS AG (DE) | 2004-08-19 | — | — | WO | claimed |
| EP-0141763-B1 | COMPOSITIONS BASED ON FIRE-PROOFED POLYAMIDES | RHONE-POULENC CHIMIE (FR) | 1987-12-02 | — | — | EP | claimed |
| EP-0039048-A1 | Process for the purification of polycarboxylic acids | Ruhrchemie Aktiengesellschaft (DE) | 1981-11-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276146-A1 | Adenine modified silica-based catalyst, a process for the preparation and use there for the production of cyclic carbonates | CA9, MCM5, CCNH | CA1 49/4885CA2 9/4885CA9 1/4885 |
| US-20260106221-A1 | LITHIUM SECONDARY BATTERY WITH ENHANCED SAFETY | BCL6B, CLCN2, SLC9A2 | CA1 103/4885CA2 18/4885CA9 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.